Frontiers in Immunology (Mar 2023)

Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients

  • Lídia Sans-de San Nicolàs,
  • Ignasi Figueras-Nart,
  • Irene García-Jiménez,
  • Montserrat Bonfill-Ortí,
  • Antonio Guilabert,
  • Laia Curto-Barredo,
  • Marta Bertolín-Colilla,
  • Marta Ferran,
  • Esther Serra-Baldrich,
  • Ramon M. Pujol,
  • Luis F. Santamaria-Babí

DOI
https://doi.org/10.3389/fimmu.2023.1124018
Journal volume & issue
Vol. 14

Abstract

Read online

BackgroundThe role of allergen sensitization in IL-31 production by T cells and specifically in the clinical context of atopic dermatitis (AD) has not been characterized.MethodsThe response to house dust mite (HDM) in purified memory T cells cocultured with epidermal cells from AD patients (n=58) and control subjects (n=11) was evaluated. AD-associated cytokines from culture supernatants, plasma proteins and mRNA expression from cutaneous lesions were assessed and related with the clinical features of the patients.ResultsHDM-induced IL-31 production by memory T cells defined two subsets of AD patients according to the presence or absence of IL-31 response. Patients in the IL-31 producing group showed a more inflammatory profile, and increased HDM-specific (sp) and total IgE levels compared to the IL-31 non-producing group. A correlation between IL-31 production and patient’s pruritus intensity, plasma CCL27 and periostin was detected. When the same patients were analyzed based on sp IgE and total IgE levels, an increased IL-31 in vitro response, as well as type 2 markers in plasma and cutaneous lesions, was found in patients with sp IgE levels > 100 kUA/L and total IgE levels > 1000 kU/L. The IL-31 response by memory T cells was restricted to the cutaneous lymphocyte-associated antigen (CLA)+ T-cell subset.ConclusionIgE sensitization to HDM allows stratifying IL-31 production by memory T cells in AD patients and relating it to particular clinical phenotypes of the disease.

Keywords